Sign Up Today and Learn More About Alpha9 Theranostics Stock
Invest in or calculate the value of your shares in Alpha9 Theranostics or other pre-IPO companies through EquityZen's platform.
Alpha9 Theranostics Stock (ALNT)
Alpha9 Theranostics is a biopharma company that focuses on radiotherapeutics for the treatment of solid and hematologic malignancies.
About Alpha9 Theranostics Stock
Founded
2019
Industries
Software, Artificial Intelligence, Data and Analytics
Alpha9 Theranostics Press Mentions
Stay in the know about the latest news on Alpha9 Theranostics
ITM, Alpha-9 enter supply agreement for Lu-177
auntminnie • Mar 02, 2024
Six radiopharmaceutical companies making a difference
labiotech • Dec 25, 2023
Alpha-9 Theranostics Strengthens its Scientific Expertise with Key Appointments to Leadership Team and Scientific Advisory Board
biospace • Mar 08, 2023
Alpha-9 Theranostics Announces Oversubscribed $75 Million Series B Financing to Advance Portfolio of Radiopharmaceuticals for Cancer
prnewswire • Dec 14, 2022
Alpha9 Theranostics Management
Leadership team at Alpha9 Theranostics
CEO
Ian McBeath
Co-Founder
David Perrin
Join now and verify your accreditation status to gain access to:
- Alpha9 Theranostics current valuation
- Alpha9 Theranostics stock price
- Available deals in Alpha9 Theranostics and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
Trading Alpha9 Theranostics Stock
How to invest in Alpha9 Theranostics stock?
Accredited investors can buy pre-IPO stock in companies like Alpha9 Theranostics through EquityZen funds. These investments are made available by existing Alpha9 Theranostics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Alpha9 Theranostics stock?
Shareholders can sell their Alpha9 Theranostics stock through EquityZen's private company marketplace. EquityZen's network includes over 340K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 44K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
